Ledger.Open graph →
SEC Form D · Amendment · filed January 12, 2021

Revere Pharmaceuticals Inc

Offering
$3.5M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ARLINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Jedd R. Levine · Arlington, MAExec · DirectorIan R. Silverman · Arlington, MAExec · DirectorKollol R. Pal · Arlington, MADirectorGeneral Partner of the General Partner 83North FXV Manager, Ltd · Herzliya, L3Exec · DirectorGerald W. Horn · Deerfield, ILDirectorJames W. Mccollum · Coronado, CAExec · DirectorJason K. Giordano · Hanover, PAExec · DirectorJohan H. Aspen · Stockholm, V7Exec · DirectorMarc Sharinn · LAKE SUCCESS, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗